Jefferies Group LLC Oramed Pharmaceuticals Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$8.19 - $13.89 $292,383 - $495,873
-35,700 Closed
0 $0
Q4 2021

Sep 21, 2023
BUY
$12.98 - $29.75 $463,386 - $1.06 Million
35,700 New
35,700 $509,000
Q4 2021

Feb 14, 2022
BUY
$12.98 - $29.75 $463,386 - $1.06 Million
35,700 New
35,700 $510,000

Others Institutions Holding ORMP

# of Institutions
62
Shares Held
5.69M
Call Options Held
8.3K
Put Options Held
2.7K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $98.6M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email